Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
The Prostaglandin market revenue was 479 Million USD in 2019, and will reach 696 Million USD in 2025, with a CAGR of 6.4% during 2020-2025. The prostaglandins (PG) are a group of physiologically active lipid compounds called eicosanoids having diverse hormone-like effects in animals. Prostaglandins have been found in almost every tissue in humans and other animals. They are derived enzymatically from the fatty acid arachidonic acid. Every prostaglandin contains 20 carbon atoms, including a 5-carbon ring. They are a subclass of eicosanoids and of the prostanoid class of fatty acid derivatives.
This report elaborates the market size, market characteristics, and market growth of the Prostaglandin industry, and breaks down according to the type, application, and consumption area of Prostaglandin. The report also introduces players in the industry from the perspective of the industry chain and marketing chain and describes the leading companies.
In Chapter 2.3 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Prostaglandin in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
Chapter 2.5 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.
In addition, chapters 6-10 consider the impact of COVID-19 on the regional economy.
Key players in the global Prostaglandin market covered in Chapter 11:
Everlight Chemical
Merck KGaA
Sanofi
Bio-Techne Corporation
EMD Millipore
Pfizer
Yonsung Fine Chemicals
Mironova Labs
Piramal Enterprises
Pharma Solutions Morpeth
Cayman Chemical
CEPIA
Johnson Matthey
Cayman Chemical
Chirogate International
In Chapter 3, on the basis of types, the Prostaglandin market from 2015 to 2025 is primarily split into:
Human Prostaglandin
Veterinary Prostaglandin
In Chapter 4, on the basis of applications, the Prostaglandin market from 2015 to 2025 covers:
Cardiovascular
Digestive
Gynecological and Obstetrical
Ophthalmologic
Other
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 5, 6, 7, 8, 9, 10:
North America (Covered in Chapter 6)
United States
Canada
Mexico
Europe (Covered in Chapter 7)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 8)
China
Japan
South Korea
Australia
India
Middle East and Africa (Covered in Chapter 9)
Saudi Arabia
UAE
Egypt
South Africa
South America (Covered in Chapter 10)
Brazil
Argentina
Columbia
2019
This report elaborates the market size, market characteristics, and market growth of the Prostaglandin industry, and breaks down according to the type, application, and consumption area of Prostaglandin. The report also introduces players in the industry from the perspective of the industry chain and marketing chain and describes the leading companies.
In Chapter 2.3 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Prostaglandin in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
Chapter 2.5 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.
In addition, chapters 6-10 consider the impact of COVID-19 on the regional economy.
Key players in the global Prostaglandin market covered in Chapter 11:
Everlight Chemical
Merck KGaA
Sanofi
Bio-Techne Corporation
EMD Millipore
Pfizer
Yonsung Fine Chemicals
Mironova Labs
Piramal Enterprises
Pharma Solutions Morpeth
Cayman Chemical
CEPIA
Johnson Matthey
Cayman Chemical
Chirogate International
In Chapter 3, on the basis of types, the Prostaglandin market from 2015 to 2025 is primarily split into:
Human Prostaglandin
Veterinary Prostaglandin
In Chapter 4, on the basis of applications, the Prostaglandin market from 2015 to 2025 covers:
Cardiovascular
Digestive
Gynecological and Obstetrical
Ophthalmologic
Other
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 5, 6, 7, 8, 9, 10:
North America (Covered in Chapter 6)
United States
Canada
Mexico
Europe (Covered in Chapter 7)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 8)
China
Japan
South Korea
Australia
India
Middle East and Africa (Covered in Chapter 9)
Saudi Arabia
UAE
Egypt
South Africa
South America (Covered in Chapter 10)
Brazil
Argentina
Columbia
Years considered for this report:
Historical Years:
2015-2019Base Year:
2019Estimated Year:
2020Forecast Period:
2020-2025Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
